The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Looking ahead to 2030, our model projects INCY could trade at an average price of $206.82, with a potential range between $155.12 and $258.53. This represents a potential 105.3% return from today's ...
The latest price target for Incyte (NASDAQ:INCY) was reported by Bernstein on May 22, 2026. The analyst firm set a price target for $99.00 expecting INCY to rise to within 12 months (a possible 2.34% ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Fintel reports that on November 24, 2025, Barclays maintained coverage of Incyte (NasdaqGS:INCY) with a Overweight recommendation. Analyst Price Forecast Suggests 7.38% Downside As of November 17, ...
Fintel reports that on May 22, 2026, Bernstein initiated coverage of Incyte (NasdaqGS:INCY) with a Market Perform recommendation. Analyst Price Forecast Suggests 13.67% Upside As of May 13, 2026, the ...
In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. Incyte Corporation is one of them. Incyte Corporation (NASDAQ:INCY), a global biopharmaceutical ...
Incyte remains attractively valued, trading at 12.5x 2026 EPS, well below sector medians, with 9% EPS and revenue growth expected. Jakafi, currently 60% of revenue, faces patent expiration in 2028; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results